Treatment of Infective Endocarditis
The treatment of infective endocarditis requires a prolonged course (4-6 weeks) of bactericidal antibiotics tailored to the causative organism, with consideration for surgical intervention in approximately 50% of cases. 1
Diagnostic Approach Before Treatment
- Obtain three sets of blood cultures at 30-minute intervals before initiating antibiotics to maximize pathogen identification 1, 2
- Perform echocardiography promptly in all suspected cases; transesophageal echocardiography (TEE) is more sensitive for detecting complications like aortic root abscesses 3
- For pediatric patients, transthoracic echocardiography (TTE) has high sensitivity (up to 97%), but TEE is recommended for those >10 years of age weighing >60 kg 3
Antimicrobial Therapy Principles
- Use bactericidal rather than bacteriostatic antibiotics whenever possible 3
- Administer antibiotics intravenously to ensure complete bioavailability and high serum concentrations 1
- Treatment duration depends on the causative organism and whether native or prosthetic valve is involved 3, 1
Organism-Specific Treatment
Streptococcal Endocarditis
- For penicillin-susceptible streptococci (native valve): Penicillin G or ceftriaxone for 4 weeks 1, 4
- For penicillin-allergic patients: Vancomycin for 4 weeks 1, 5
- For prosthetic valve streptococcal endocarditis: Extend treatment to 6 weeks 3
Staphylococcal Endocarditis
- For methicillin-susceptible S. aureus (native valve): Nafcillin, oxacillin, or cefazolin for 4-6 weeks 1, 6
- For methicillin-resistant S. aureus: Vancomycin for 6 weeks 1, 5
- For prosthetic valve staphylococcal endocarditis: Add rifampin throughout treatment and gentamicin for first 2 weeks, with total duration of at least 6 weeks 3, 6, 7
Enterococcal Endocarditis
- Combination therapy with penicillin/ampicillin plus gentamicin for 4-6 weeks 1, 8
- For vancomycin-treated enterococcal endocarditis: Extend treatment to 6 weeks 3
- Aminoglycoside duration can be limited to 2 weeks to reduce toxicity while maintaining efficacy 7, 8
HACEK Organisms
- Ceftriaxone for 4 weeks in native valve endocarditis and 6 weeks in prosthetic valve endocarditis 1
Non-HACEK Gram-Negative Bacteria
- Early surgery plus long-term therapy (at least 6 weeks) with bactericidal combinations of beta-lactams and aminoglycosides 3
- Consider adding quinolones or cotrimoxazole in some cases 3
Fungal Endocarditis
- Combined antifungal therapy and surgical valve replacement due to high mortality (>50%) 3
Blood Culture-Negative Infective Endocarditis
- Consult with infectious disease specialist from the Endocarditis Team 3
- Treatment depends on suspected pathogen (see table below for specific regimens) 3
Empiric Treatment
- Start empiric therapy promptly after blood cultures are drawn, especially in severely ill patients 1, 2
- For native valve community-acquired infection: Ampicillin + (flu)cloxacillin/oxacillin + gentamicin 9
- For penicillin-allergic patients: Vancomycin + gentamicin 9
- For prosthetic valve or healthcare-associated infection: Vancomycin + gentamicin + rifampin 2
Duration of Therapy
- Native valve highly susceptible streptococci: 4 weeks 3
- Native valve staphylococci (susceptible to oxacillin): 4-6 weeks 3
- Native valve staphylococci (resistant to oxacillin): 6 weeks 3
- Prosthetic valve staphylococci: At least 6 weeks 3
- Enterococcal endocarditis: 4-6 weeks 3
- HACEK endocarditis: 4 weeks for native valve, 6 weeks for prosthetic valve 3, 1
Surgical Considerations
- Early consultation with cardiac surgery is recommended 1
- Main indications for surgery include:
Monitoring During Treatment
- Repeat blood cultures until sterile to assess treatment adequacy 9
- For patients receiving vancomycin and aminoglycosides, monitor drug levels and renal function weekly 9
- Repeat echocardiography if there is suspicion of new complications 2
Special Considerations
- Outpatient parenteral antibiotic therapy may be considered for stable patients after initial hospitalization 3
- Management by a multidisciplinary "Endocarditis Team" is recommended for complex cases 1
- For persistent or relapsing S. aureus bacteremia/endocarditis, obtain repeat blood cultures and consider surgical intervention 10